semaglutide pad stride study STRIDE: GLP-1 Boosts Walking Capacity in Diabetic Patients 🎙️NEW #ADA2025 #LBCT Interview 💫Dr – Weekly Semaglutide Boosts PAD Function:

We dont have 10-year safety follow-ups

These positive results prompted the first clinical trial of exenatide in treating patients with IIH

These resources may help you choose next steps with more confidence: Muscle, Performance & Body Composition Playbook decision guidance & sequencing Muscle, Performance & Body Composition Support Foundation supports recovery and metabolic capacity No pressure

GLP-1 Benefits In addition to helping people achieve a healthier weight, GLP-1s provide a variety of health benefits: Type 2 diabetes: GLP-1s are used to treat type 2 diabetes

Most studies I have read seem to point to 25 mg a day being the dose upon which going above doesnt make sense